β-Adrenergic stimulation and myocardial function in the failing heart

Heart Failure Reviews

Volumn 14, Issue 4, 2009, Pages 225-241

  El Armouche, Ali ^a   Eschenhagen, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Adrenergic signaling; Betablocker; Contractility; Heart failure; Inotropes; Transgenic mice

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN RECEPTOR ANTAGONIST; GUANINE NUCLEOTIDE BINDING PROTEIN; INOTROPIC AGENT; METOPROLOL; MOXONIDINE; PHOSPHODIESTERASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; BETA ADRENERGIC STIMULATION; DESENSITIZATION; EXCITATION CONTRACTION COUPLING; GENE TARGETING; GENETIC ENGINEERING; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HUMAN; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW;

ANIMALS; HEART FAILURE; HUMANS; MICE; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; PHARMACOGENETICS; RECEPTORS, ADRENERGIC, BETA;

EID: 70449116100     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-008-9132-8     Document Type: Review

References (182)

1. F Waagstein A Hjalmarson E Varnauskas I Wallentin 1975 Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy Br Heart J 37 1022 1036 10.1136/hrt.37.10.1022 1191416
2. T Eschenhagen 2008 Beta-adrenergic signaling in heart failure-adapt or die Nat Med 14 485 487 10.1038/nm0508-485 18463653 (Pubitemid 351655199)
3. OE Brodde MC Michel 1999 Adrenergic and muscarinic receptors in the human heart Pharmacol Rev 51 651 690 10581327
4. HA Rockman WJ Koch RJ Lefkowitz 2002 Seven-transmembrane-spanning receptors and heart function Nature 415 206 212 10.1038/415206a 11805844 (Pubitemid 34059526)
5. OE Brodde H Bruck K Leineweber 2006 Cardiac adrenoceptors: physiological and pathophysiological relevance J Pharmacol Sci 100 323 337 10.1254/jphs.CRJ06001X 16612046 (Pubitemid 44609527)
6. M Kang KY Chung JW Walker 2007 G-protein coupled receptor signaling in myocardium: not for the faint of heart Physiology (Bethesda) 22 174 184 10.1152/physiol.00051.2006
7. Y Xiang BK Kobilka 2003 Myocyte adrenoceptor signaling pathways Science 300 1530 1532 10.1126/science.1079206 12791980 (Pubitemid 36682874)
8. MJ Lohse S Engelhardt T Eschenhagen 2003 What is the role of beta-adrenergic signaling in heart failure? Circ Res 93 896 906 10.1161/01.RES.0000102042.83024.CA 14615493 (Pubitemid 37433227)
9. JD Port MR Bristow 2001 Beta-Adrenergic receptors, transgenic mice, and pharmacological model systems Mol Pharmacol 60 629 631 11562422
10. C Gauthier V Leblais L Kobzik JN Trochu N Khandoudi A Bril JL Balligand H Le Marec 1998 The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle J Clin Invest 102 1377 1384 10.1172/JCI2191 9769330
11. AD Strosberg 1997 Structure and function of the beta 3-adrenergic receptor Annu Rev Pharmacol Toxicol 37 421 450 10.1146/annurev.pharmtox.37.1.421 9131260
12. N Defer M Best-Belpomme J Hanoune 2000 Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase Am J Physiol Renal Physiol 279 F400 F416 10966920
13. RP Xiao W Zhu M Zheng C Cao Y Zhang EG Lakatta Q Han 2006 Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart Trends Pharmacol Sci 27 330 337 10.1016/j.tips.2006.04.009 16697055 (Pubitemid 43850004)
14. W Zhu X Zeng M Zheng RP Xiao 2005 The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly Circ Res 97 507 509 10.1161/01.RES.0000184615.56822.bd 16166560 (Pubitemid 41361739)
15. P Molenaar SM Savarimuthu D Sarsero L Chen AB Semmler A Carle I Yang S Bartel D Vetter I Beyerdorfer EG Krause AJ Kaumann 2007 (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling Naunyn Schmiedebergs Arch Pharmacol 375 11 28 10.1007/s00210-007-0138-x 17295024 (Pubitemid 46354559)
16. DM Bers 2002 Cardiac excitation-contraction coupling Nature 415 198 205 10.1038/415198a 11805843 (Pubitemid 34059525)
17. DM Bers 2008 Calcium cycling and signaling in cardiac myocytes Annu Rev Physiol 70 23 49 10.1146/annurev.physiol.70.113006.100455 17988210 (Pubitemid 351738170)
18. ST Rapundalo 1998 Cardiac protein phosphorylation: functional and pathophysiological correlates Cardiovasc Res 38 559 588 10.1016/S0008-6363(98) 00063-7 9747427 (Pubitemid 28319868)
19. HK Simmerman LR Jones 1998 Phospholamban: protein structure, mechanism of action, and role in cardiac function Physiol Rev 78 921 947 9790566
20. W Luo IL Grupp J Harrer S Ponniah G Grupp JJ Duffy T Doetschman EG Kranias 1994 Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation Circ Res 75 401 409 8062415
21. DH MacLennan EG Kranias 2003 Phospholamban: a crucial regulator of cardiac contractility Nat Rev Mol Cell Biol 4 566 577 10.1038/nrm1151 12838339 (Pubitemid 36773408)
22. T Kobayashi RJ Solaro 2005 Calcium, thin filaments, and the integrative biology of cardiac contractility Annu Rev Physiol 67 39 67 10.1146/annurev. physiol.67.040403.114025 15709952 (Pubitemid 40404485)
23. L Carrier 2007 Cardiac myosin-binding protein C in the heart Arch Mal Coeur Vaiss 100 238 243 17536430
24. CJ Palmer BT Scott LR Jones 1991 Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium J Biol Chem 266 11126 11130 1710217
25. S Despa J Bossuyt F Han KS Ginsburg LG Jia H Kutchai AL Tucker DM Bers 2005 Phospholemman-phosphorylation mediates the beta-adrenergic effects on Na/K pump function in cardiac myocytes Circ Res 97 252 259 10.1161/01.RES.0000176532. 97731.e5 16002746 (Pubitemid 41105451)
26. IM Mansuy S Shenolikar 2006 Protein serine/threonine phosphatases in neuronal plasticity and disorders of learning and memory Trends Neurosci 29 679 686 10.1016/j.tins.2006.10.004 17084465 (Pubitemid 44794536)
27. PT Cohen 2002 Protein phosphatase 1-targeted in many directions J Cell Sci 115 241 256 11839776
28. H Ceulemans M Bollen 2004 Functional diversity of protein phosphatase-1, a cellular economizer and reset button Physiol Rev 84 1 39 10.1152/physrev. 00013.2003 14715909 (Pubitemid 38049874)
29. S Herzig J Neumann 2000 Effects of serine/threonine protein phosphatases on ion channels in excitable membranes Physiol Rev 80 173 210 10617768
30. AR Marks SO Marx S Reiken 2002 Regulation of ryanodine receptors via macromolecular complexes: a novel role for leucine/isoleucine zippers Trends Cardiovasc Med 12 166 170 10.1016/S1050-1738(02)00156-1 12069756 (Pubitemid 34586820)
31. LK MacDougall LR Jones P Cohen 1991 Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban Eur J Biochem 196 725 734 10.1111/j.1432-1033.1991.tb15871.x 1849481
32. H Luss O Klein-Wiele P Boknik S Herzig J Knapp B Linck FU Muller HH Scheld C Schmid W Schmitz J Neumann 2000 Regional expression of protein phosphatase type 1 and 2A catalytic subunit isoforms in the human heart J Mol Cell Cardiol 32 2349 2359 10.1006/jmcc.2000.1265 11113010 (Pubitemid 32042138)
33. B Lygren CR Carlson K Santamaria V Lissandron T McSorley J Litzenberg D Lorenz B Wiesner W Rosenthal M Zaccolo K Tasken E Klussmann 2007 AKAP complex regulates Ca2 + re-uptake into heart sarcoplasmic reticulum EMBO Rep 8 1061 1067 10.1038/sj.embor.7401081 17901878 (Pubitemid 350042342)
34. MA Fink DR Zakhary JA Mackey RW Desnoyer C Apperson-Hansen DS Damron M Bond 2001 AKAP-mediated targeting of protein kinase a regulates contractility in cardiac myocytes Circ Res 88 291 297 11179196
35. KL Dodge-Kafka L Langeberg JD Scott 2006 Compartmentation of cyclic nucleotide signaling in the heart: the role of A-kinase anchoring proteins Circ Res 98 993 1001 10.1161/01.RES.0000218273.91741.30 16645149 (Pubitemid 43755220)
36. A El-Armouche T Rau O Zolk D Ditz T Pamminger WH Zimmermann E Jackel SE Harding P Boknik J Neumann T Eschenhagen 2003 Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes FASEB J 17 437 439 12514122
37. AN Carr AG Schmidt Y Suzuki F del Monte Y Sato C Lanner K Breeden SL Jing PB Allen P Greengard A Yatani BD Hoit IL Grupp RJ Hajjar AA DePaoli-Roach EG Kranias 2002 Type 1 phosphatase, a negative regulator of cardiac function Mol Cell Biol 22 4124 4135 10.1128/MCB.22.12.4124-4135.2002 12024026 (Pubitemid 34556583)
38. J Neumann RC Gupta W Schmitz H Scholz AC Nairn AM Watanabe 1991 Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor-1 in the intact heart Circ Res 69 1450 1457 1659500
39. RM Mulkey S Endo S Shenolikar RC Malenka 1994 Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression Nature 369 486 488 10.1038/369486a0 7515479
40. A El-Armouche A Bednorz T Pamminger D Ditz M Didie D Dobrev T Eschenhagen 2006 Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes Biochem Biophys Res Commun 346 700 706 10.1016/j.bbrc.2006.05.182 16774736 (Pubitemid 43913676)
41. A El-Armouche K Wittkopper F Degenhardt F Weinberger M Didie I Melnychenko M Grimm M Peeck WH Zimmermann B Unsold G Hasenfuss D Dobrev T Eschenhagen 2008 Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy Cardiovasc Res 80 396 406 18689792
42. RD Blitzer JH Connor GP Brown T Wong S Shenolikar R Iyengar EM Landau 1998 Gating of CaMKII by cAMP-regulated protein phosphatase activity during LTP Science 280 1940 1942 10.1126/science.280.5371.1940 9632393 (Pubitemid 28299402)
43. R Fischmeister LR Castro A Abi-Gerges F Rochais J Jurevicius J Leroy G Vandecasteele 2006 Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases Circ Res 99 816 828 10.1161/01.RES.0000246118.98832.04 17038651 (Pubitemid 44556380)
44. UB Kaupp R Seifert 2002 Cyclic nucleotide-gated ion channels Physiol Rev 82 769 824 12087135
45. M Biel A Schneider C Wahl 2002 Cardiac HCN channels: structure, function, and modulation Trends Cardiovasc Med 12 206 212 10.1016/S1050-1738(02)00162-7 12161074 (Pubitemid 34823630)
46. H Rehmann F Schwede SO Doskeland A Wittinghofer JL Bos 2003 Ligand-mediated activation of the cAMP-responsive guanine nucleotide exchange factor Epac J Biol Chem 278 38548 38556 10.1074/jbc.M306292200 12888551 (Pubitemid 37221750)
47. E Morel A Marcantoni M Gastineau R Birkedal F Rochais A Garnier AM Lompre G Vandecasteele F Lezoualc'h 2005 cAMP-binding protein Epac induces cardiomyocyte hypertrophy Circ Res 97 1296 1304 16269655
48. F Lezoualc'h M Metrich I Hmitou N Duquesnes E Morel 2008 Small GTP-binding proteins and their regulators in cardiac hypertrophy J Mol Cell Cardiol 44 623 632 10.1016/j.yjmcc.2008.01.011 18339399
49. M Metrich A Lucas M Gastineau JL Samuel C Heymes E Morel F Lezoualc'h 2008 Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy Circ Res 102 959 965 10.1161/CIRCRESAHA.107.164947 18323524 (Pubitemid 351591548)
50. MA Movsesian MR Bristow 2005 Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy Curr Top Dev Biol 68 25 48 10.1016/S0070-2153(05)68002-7 16124995
51. A El-Armouche O Zolk T Rau T Eschenhagen 2003 Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure Cardiovasc Res 60 478 487 10.1016/j.cardiores.2003.09.014 14659793 (Pubitemid 37501105)
52. SF Vatner DE Vatner CJ Homcy 2000 Beta-adrenergic receptor signaling: an acute compensatory adjustment-inappropriate for the chronic stress of heart failure? Insights from Gsalpha overexpression and other genetically engineered animal models Circ Res 86 502 506 10720410
53. GW Dorn II JD Molkentin 2004 Manipulating cardiac contractility in heart failure: data from mice and men Circulation 109 150 158 10.1161/01.CIR. 0000111581.15521.F5 14734503 (Pubitemid 38114132)
54. JO Mudd DA Kass 2008 Tackling heart failure in the twenty-first century Nature 451 919 928 10.1038/nature06798 18288181 (Pubitemid 351301747)
55. DL Mann MR Bristow 2005 Mechanisms and models in heart failure: the biomechanical model and beyond Circulation 111 2837 2849 10.1161/CIRCULATIONAHA. 104.500546 15927992 (Pubitemid 40791557)
56. WS Colucci AR Denniss GF Leatherman RJ Quigg PL Ludmer JD Marsh DF Gauthier 1988 Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition J Clin Invest 81 1103 1110 10.1172/JCI113423 2832444
57. MD Feldman L Copelas JK Gwathmey P Phillips SE Warren FJ Schoen W Grossman JP Morgan 1987 Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure Circulation 75 331 339 2433073
58. M Bohm D Beuckelmann L Brown G Feiler B Lorenz M Nabauer B Kemkes E Erdmann 1988 Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium Eur Heart J 9 844 852 2460351
59. SR Houser KB Margulies 2003 Is depressed myocyte contractility centrally involved in heart failure? Circ Res 92 350 358 10.1161/01.RES.0000060027.40275. A6 12623873 (Pubitemid 36298194)
60. G Hasenfuss 1998 Alterations of calcium-regulatory proteins in heart failure Cardiovasc Res 37 279 289 10.1016/S0008-6363(97)00277-0 9614485 (Pubitemid 28165990)
61. G Hasenfuss B Pieske 2002 Calcium cycling in congestive heart failure J Mol Cell Cardiol 34 951 969 10.1006/jmcc.2002.2037 12234765 (Pubitemid 35316143)
62. T Eschenhagen 1993 G proteins and the heart Cell Biol Int 17 723 749 10.1006/cbir.1993.1135 8220302 (Pubitemid 23280358)
63. MR Bristow R Ginsburg W Minobe RS Cubicciotti WS Sageman K Lurie ME Billingham DC Harrison EB Stinson 1982 Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts N Engl J Med 307 205 211 6283349
64. S Engelhardt M Bohm E Erdmann MJ Lohse 1996 Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure J Am Coll Cardiol 27 146 154 10.1016/0735-1097(95)00425-4 8522688
65. M Ungerer M Bohm JS Elce E Erdmann MJ Lohse 1993 Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart Circulation 87 454 463 8381058
66. AM Feldman AE Cates WB Veazey RE Hershberger MR Bristow KL Baughman WA Baumgartner C Van Dop 1988 Increase of the 40, 000-mol wt pertussis toxin substrate (G protein) in the failing human heart J Clin Invest 82 189 197 10.1172/JCI113569 2839545
67. J Neumann W Schmitz H Scholz L von Meyerinck V Doring P Kalmar 1988 Increase in myocardial Gi-proteins in heart failure Lancet 2 936 937 10.1016/S0140-6736(88)92601-3 2902384
68. M Böhm P Gierschik KH Jakobs B Pieske P Schnabel M Ungerer E Erdmann 1990 Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy Circulation 82 1249 1265 2169357
69. T Eschenhagen U Mende M Nose W Schmitz H Scholz A Haverich S Hirt V Doring P Kalmar W Hoppner, et al. 1992 Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure Circ Res 70 688 696 1551195
70. A El-Armouche T Pamminger D Ditz O Zolk T Eschenhagen 2004 Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts Cardiovasc Res 61 87 93 10.1016/j.cardiores.2003.11.005 14732205 (Pubitemid 38056684)
71. J Neumann T Eschenhagen LR Jones B Linck W Schmitz H Scholz N Zimmermann 1997 Increased expression of cardiac phosphatases in patients with end-stage heart failure J Mol Cell Cardiol 29 265 272 10.1006/jmcc.1996.0271 9040041 (Pubitemid 27129150)
72. D Diviani 2008 Modulation of cardiac function by A-kinase anchoring proteins Curr Opin Pharmacol 8 166 173 10.1016/j.coph.2007.11.001 18165153
73. DR Zakhary CS Moravec M Bond 2000 Regulation of PKA binding to AKAPs in the heart: alterations in human heart failure Circulation 101 1459 1464 10736293
74. S Bartel B Stein T Eschenhagen U Mende J Neumann W Schmitz EG Krause P Karczewski H Scholz 1996 Protein phosphorylation in isolated trabeculae from nonfailing and failing human hearts Mol Cell Biochem 157 171 179 10.1007/BF00227896 8739244
75. A El-Armouche L Pohlmann S Schlossarek J Starbatty YH Yeh S Nattel D Dobrev T Eschenhagen L Carrier 2007 Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure J Mol Cell Cardiol 43 223 229 10.1016/j.yjmcc.2007.05.003 17560599 (Pubitemid 47079047)
76. GS Bodor AE Oakeley PD Allen DL Crimmins JH Ladenson PA Anderson 1997 Troponin I phosphorylation in the normal and failing adult human heart Circulation 96 1495 1500 9315537
77. AE Messer AM Jacques SB Marston 2007 Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure J Mol Cell Cardiol 42 247 259 10.1016/j.yjmcc.2006.08.017 17081561 (Pubitemid 44970468)
78. F Schroder R Handrock DJ Beuckelmann S Hirt R Hullin L Priebe RH Schwinger J Weil S Herzig 1998 Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle Circulation 98 969 976 9737516
79. SO Marx S Reiken Y Hisamatsu T Jayaraman D Burkhoff N Rosemblit AR Marks 2000 PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts Cell 101 365 376 10.1016/S0092-8674(00)80847-8 10830164
80. NA Benkusky CS Weber JA Scherman EF Farrell TA Hacker MC John PA Powers HH Valdivia 2007 Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor Circ Res 101 819 829 10.1161/CIRCRESAHA.107.153007 17717301 (Pubitemid 350287197)
81. S Lehnart AR Marks 2007 Regulation of ryanodine receptors in the heart Circ Res 101 746 749 10.1161/CIRCRESAHA.107.162479 17932330 (Pubitemid 350287186)
82. OE Osadchii 2007 Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects Heart Fail Rev 12 66 86 10.1007/s10741-007-9007-4 17387610 (Pubitemid 46629248)
83. A El-Armouche F Gocht E Jaeckel K Wittkopper M Peeck T Eschenhagen 2007 Long-term beta-adrenergic stimulation leads to downregulation of protein phosphatase inhibitor-1 in the heart Eur J Heart Fail 9 1077 1080 10.1016/j.ejheart.2007.09.006 17921049 (Pubitemid 47633319)
84. P Boknik M Fockenbrock S Herzig J Knapp B Linck H Luss FU Muller T Muller W Schmitz F Schroder J Neumann 2000 Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation Naunyn Schmiedebergs Arch Pharmacol 362 222 231 10.1007/s002100000283 10997724 (Pubitemid 30679077)
85. T Eschenhagen U Mende M Diederich M Nose W Schmitz H Scholz J Schulte am Esch A Warnholtz H Schafer 1992 Long term beta-adrenoceptor-mediated up-regulation of Gi alpha and G(o) alpha mRNA levels and pertussis toxin-sensitive guanine nucleotide-binding proteins in rat heart Mol Pharmacol 42 773 783 1331760
86. U Mende T Eschenhagen B Geertz W Schmitz H Scholz J Schulte am Esch R Sempell M Steinfath 1992 Isoprenaline-induced increase in the 40/41 kDa pertussis toxin substrates and functional consequences on contractile response in rat heart Naunyn Schmiedebergs Arch Pharmacol 345 44 50 10.1007/BF00175468 1311426
87. JN Cohn TB Levine MT Olivari V Garberg D Lura GS Francis AB Simon T Rector 1984 Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 819 823 6382011
88. MD Faulx P Ernsberger D Vatner RD Hoffman W Lewis R Strachan BD Hoit 2005 Strain-dependent beta-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice Am J Physiol Heart Circ Physiol 289 H30 H36 10.1152/ajpheart.00636.2004 15749746 (Pubitemid 40934079)
89. SB Liggett S Cresci RJ Kelly FM Syed SJ Matkovich HS Hahn A Diwan JS Martini L Sparks RR Parekh JA Spertus WJ Koch SL Kardia GW Dorn II 2008 A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure Nat Med 14 510 517 10.1038/nm1750 18425130 (Pubitemid 351655214)
90. CM O'Connor WA Gattis BF Uretsky KF Adams Jr SE McNulty SH Grossman WJ McKenna F Zannad K Swedberg M Gheorghiade RM Califf 1999 Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST) Am Heart J 138 78 86 10.1016/S0002-8703(99)70250-4 10385768 (Pubitemid 29331125)
91. AM Feldman MR Bristow WW Parmley PE Carson CJ Pepine EM Gilbert JE Strobeck GH Hendrix ER Powers RP Bain, et al. 1993 Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group The New England Journal of Medicine 329 149 155 10.1056/NEJM199307153290301 8515787 (Pubitemid 23195734)
92. LW Stevenson 2003 Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy Circulation 108 492 497 10.1161/01.CIR.0000078349.43742.8A 12885733 (Pubitemid 36935545)
93. S Satwani GW Dec J Narula 2004 Beta-adrenergic blockers in heart failure: review of mechanisms of action and clinical outcomes J Cardiovasc Pharmacol Ther 9 243 255 10.1177/107424840400900404 15678243 (Pubitemid 40130011)
94. MR Bristow 2000 Beta-adrenergic receptor blockade in chronic heart failure Circulation 101 558 569 10662755
95. M Packer 2001 Current role of beta-adrenergic blockers in the management of chronic heart failure Am J Med 110 Suppl 7A 81S 94S 10.1016/S0002-9343(01) 00676-3 11334782
96. JO Mudd DA Kass 2007 Reversing chronic remodeling in heart failure Expert Rev Cardiovasc Ther 5 585 598 10.1586/14779072.5.3.585 17489680 (Pubitemid 46805584)
97. BD Lowes EM Gilbert WT Abraham WA Minobe P Larrabee D Ferguson EE Wolfel J Lindenfeld T Tsvetkova AD Robertson RA Quaife MR Bristow 2002 Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents N Engl J Med 346 1357 1365 10.1056/NEJMoa012630 11986409 (Pubitemid 34754608)
98. SA Hall CG Cigarroa L Marcoux RC Risser PA Grayburn EJ Eichhorn 1995 Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade J Am Coll Cardiol 25 1154 1161 10.1016/0735-1097(94)00543-Y 7897129
99. JR Hadcock JD Port CC Malbon 1991 Cross-regulation between G-protein-mediated pathways. Activation of the inhibitory pathway of adenylylcylclase increases the expression of beta 2-adrenergic receptors J Biol Chem 266 11915 11922 1646818
100. T Eschenhagen M Friedrichsen S Gsell A Hollmann C Mittmann W Schmitz H Scholz J Weil LS Weinstein 1996 Regulation of the human Gi alpha-2 gene promotor activity in embryonic chicken cardiomyocytes Basic Res Cardiol 91 Suppl 2 41 46 10.1007/BF00795361 8957543
101. V Regitz-Zagrosek R Hertrampf C Steffen A Hildebrandt E Fleck 1994 Myocardial cyclic AMP and norepinephrine content in human heart failure Eur Heart J 15 Suppl D 7 13 7713118
102. S Lee RH Schwinger K Brixius 2008 Genetically changed mice with chronic deficiency or overexpression of the beta-adrenoceptors-what can we learn for the therapy of heart failure? Pflugers Arch 455 767 774 10.1007/s00424-007-0324-1 17874127 (Pubitemid 350265613)
103. C Gaudin Y Ishikawa DC Wight V Mahdavi B Nadal-Ginard TE Wagner DE Vatner CJ Homcy 1995 Overexpression of Gs alpha protein in the hearts of transgenic mice J Clin Invest 95 1676 1683 10.1172/JCI117843 7706476
104. CL Antos N Frey SO Marx S Reiken M Gaburjakova JA Richardson AR Marks EN Olson 2001 Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a Circ Res 89 997 1004 10.1161/hh2301.100003 11717156
105. S Engelhardt L Hein F Wiesmann MJ Lohse 1999 Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice Proc Natl Acad Sci USA 96 7059 7064 10.1073/pnas.96.12.7059 10359838 (Pubitemid 29275009)
106. M Iwase M Uechi DE Vatner K Asai RP Shannon RK Kudej TE Wagner DC Wight TA Patrick Y Ishikawa CJ Homcy SF Vatner 1997 Cardiomyopathy induced by cardiac Gs alpha overexpression Am J Physiol 272 H585 H589 9038982
107. SB Liggett NM Tepe JN Lorenz AM Canning TD Jantz S Mitarai A Yatani GW Dorn II 2000 Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level Circulation 101 1707 1714 10758054
108. HR Cross C Steenbergen RJ Lefkowitz WJ Koch E Murphy 1999 Overexpression of the cardiac beta(2)-adrenergic receptor and expression of a beta-adrenergic receptor kinase-1 (betaARK1) inhibitor both increase myocardial contractility but have differential effects on susceptibility to ischemic injury Circ Res 85 1077 1084 10571539
109. XJ Du DJ Autelitano RJ Dilley B Wang AM Dart EA Woodcock 2000 Beta(2)-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis Circulation 101 71 77 10618307
110. BR DeGeorge WJ Koch 2008 Gi/o signaling and its potential role in cardioprotection Expert Rev Cardiovasc Ther 6 785 787 10.1586/14779072.6.6.785 18570615
111. K Foerster F Groner J Matthes WJ Koch L Birnbaumer S Herzig 2003 Cardioprotection specific for the G protein Gi2 in chronic adrenergic signaling through beta 2-adrenoceptors Proc Natl Acad Sci USA 100 14475 14480 10.1073/pnas.1936026100 14612574 (Pubitemid 37499261)
112. SE Lehnart XH Wehrens S Reiken S Warrier AE Belevych RD Harvey W Richter SL Jin M Conti AR Marks 2005 Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias Cell 123 25 35 10.1016/j.cell.2005.07.030 16213210 (Pubitemid 41414526)
113. M Brede F Wiesmann R Jahns K Hadamek C Arnolt S Neubauer MJ Lohse L Hein 2002 Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure Circulation 106 2491 2496 10.1161/01.CIR.0000036600.39600.66 12417548 (Pubitemid 35278807)
114. K Asai GP Yang YJ Geng G Takagi S Bishop Y Ishikawa RP Shannon TE Wagner DE Vatner CJ Homcy SF Vatner 1999 Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse J Clin Invest 104 551 558 10.1172/JCI7418 10487769
115. NC Lai T Tang MH Gao M Saito T Takahashi DM Roth HK Hammond 2008 Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice J Am Coll Cardiol 51 1490 1497 10.1016/j.jacc.2008.01.015 18402905
116. DM Roth H Bayat JD Drumm MH Gao JS Swaney A Ander HK Hammond 2002 Adenylyl cyclase increases survival in cardiomyopathy Circulation 105 1989 1994 10.1161/01.CIR.0000014968.54967.D3 11997288 (Pubitemid 34437629)
117. VB Harding LR Jones RJ Lefkowitz WJ Koch HA Rockman 2001 Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure Proc Natl Acad Sci USA 98 5809 5814 10.1073/pnas.091102398 11331748 (Pubitemid 32435724)
118. PW Raake LE Vinge E Gao M Boucher G Rengo X Chen BR DeGeorge Jr S Matkovich SR Houser P Most AD Eckhart GW Dorn II WJ Koch 2008 G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure Circ Res 103 413 422 10.1161/CIRCRESAHA.107. 168336 18635825
119. MH Gao NC Lai DM Roth J Zhou J Zhu T Anzai N Dalton HK Hammond 1999 Adenylylcyclase increases responsiveness to catecholamine stimulation in transgenic mice Circulation 99 1618 1622 10096940
120. HM Phan MH Gao NC Lai T Tang HK Hammond 2007 New signaling pathways associated with increased cardiac adenylyl cyclase 6 expression: implications for possible congestive heart failure therapy Trends Cardiovasc Med 17 215 221 10.1016/j.tcm.2007.07.001 17936202 (Pubitemid 47532726)
121. S Okumura J Kawabe A Yatani G Takagi MC Lee C Hong J Liu I Takagi J Sadoshima DE Vatner SF Vatner Y Ishikawa 2003 Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation Circ Res 93 364 371 10.1161/01.RES.0000086986.35568.63 12869393 (Pubitemid 37048249)
122. PB Allen O Hvalby V Jensen ML Errington M Ramsay FA Chaudhry TV Bliss J Storm-Mathisen RG Morris P Andersen P Greengard 2000 Protein phosphatase-1 regulation in the induction of long-term potentiation: heterogeneous molecular mechanisms J Neurosci 20 3537 3543 10804194
123. S Okumura G Takagi J Kawabe G Yang MC Lee C Hong J Liu DE Vatner J Sadoshima SF Vatner Y Ishikawa 2003 Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload Proc Natl Acad Sci USA 100 9986 9990 10.1073/pnas.1733772100 12904575 (Pubitemid 37087055)
124. S Okumura DE Vatner R Kurotani Y Bai S Gao Z Yuan K Iwatsubo C Ulucan J Kawabe K Ghosh SF Vatner Y Ishikawa 2007 Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress Circulation 116 1776 1783 10.1161/CIRCULATIONAHA.107.698662 17893275 (Pubitemid 350287102)
125. L Yan DE Vatner JP O'Connor A Ivessa H Ge W Chen S Hirotani Y Ishikawa J Sadoshima SF Vatner 2007 Type 5 adenylyl cyclase disruption increases longevity and protects against stress Cell 130 247 258 10.1016/j.cell.2007.05.038 17662940 (Pubitemid 47081133)
126. K Iwatsubo S Minamisawa T Tsunematsu M Nakagome Y Toya JE Tomlinson S Umemura RM Scarborough DE Levy Y Ishikawa 2004 Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deterioration J Biol Chem 279 40938 40945 10.1074/jbc.M314238200 15262973 (Pubitemid 39287693)
127. A Pathak F del Monte W Zhao JE Schultz JN Lorenz I Bodi D Weiser H Hahn AN Carr F Syed N Mavila L Jha J Qian Y Marreez G Chen DW McGraw EK Heist JL Guerrero AA DePaoli-Roach RJ Hajjar EG Kranias 2005 Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1 Circ Res 96 756 766 10.1161/01.RES.0000161256.85833.fa 15746443 (Pubitemid 40559515)
128. ZM Chen HC Pan YP Chen R Peto R Collins LX Jiang JX Xie LS Liu 2005 Early intravenous then oral metoprolol in 45, 852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 1622 1632 10.1016/S0140-6736(05)67661-1 16271643 (Pubitemid 41552417)
129. OE Brodde 2008 Beta-1 and beta-2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses Pharmacol Ther 117 1 29 10.1016/j.pharmthera.2007.07.002 17916379 (Pubitemid 350193335)
130. DA Mason JD Moore SA Green SB Liggett 1999 A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor J Biol Chem 274 12670 12674 10.1074/jbc.274.18.12670 10212248 (Pubitemid 29215505)
131. KM Small SL Forbes FF Rahman KM Bridges SB Liggett 2000 A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors J Biol Chem 275 23059 23064 10.1074/jbc.M000796200 10801795 (Pubitemid 30646196)
132. KM Small LE Wagoner AM Levin SL Kardia SB Liggett 2002 Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure N Engl J Med 347 1135 1142 10.1056/NEJMoa020803 12374873
133. SB Liggett J Mialet-Perez S Thaneemit-Chen SA Weber SM Greene D Hodne B Nelson J Morrison MJ Domanski LE Wagoner WT Abraham JL Anderson JF Carlquist HJ Krause-Steinrauf LC Lazzeroni JD Port PW Lavori MR Bristow 2006 A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure Proc Natl Acad Sci USA 103 11288 11293 10.1073/pnas.0509937103 16844790 (Pubitemid 44156511)
134. AJ Sehnert SE Daniels M Elashoff JA Wingrove CR Burrow B Horne JB Muhlestein M Donahue SB Liggett JL Anderson WE Kraus 2008 Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol J Am Coll Cardiol 52 644 651 10.1016/j.jacc.2008.05.022 18702968
135. JR Teerlink 2002 Recent heart failure trials of neurohormonal modulation (OVERTURE and ENABLE): approaching the asymptote of efficacy? J Card Fail 8 124 127 10.1054/jcaf.2002.126486 12140803 (Pubitemid 34857276)
136. JN Cohn MA Pfeffer J Rouleau N Sharpe K Swedberg M Straub C Wiltse TJ Wright 2003 Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON) Eur J Heart Fail 5 659 667 10.1016/S1388-9842(03)00163-6 14607206 (Pubitemid 38043972)
137. SD Anker AJ Coats 2002 How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH Int J Cardiol 86 123 130 10.1016/S0167-5273(02)00470-9 12419548 (Pubitemid 35284800)
138. MA Pfeffer JJ McMurray EJ Velazquez JL Rouleau L Kober AP Maggioni SD Solomon K Swedberg F Van de Werf H White JD Leimberger M Henis S Edwards S Zelenkofske MA Sellers RM Califf 2003 Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both N Engl J Med 349 1893 1906 10.1056/NEJMoa032292 14610160 (Pubitemid 37409706)
139. JG Cleland AP Coletta AT Abdellah D Cullington AL Clark AS Rigby 2008 Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy Eur J Heart Fail 10 102 108 10.1016/j.ejheart.2007.12.004 18179987
140. M Komajda F Follath K Swedberg J Cleland JC Aguilar A Cohen-Solal R Dietz A Gavazzi WH Van Gilst R Hobbs J Korewicki HC Madeira VS Moiseyev I Preda J Widimsky N Freemantle J Eastaugh J Mason 2003 The EuroHeart Failure Survey programme-a survey on the quality of care among patients with heart failure in Europe Part. 2: treatment Eur Heart J 24 464 474 10.1016/S0195-668X(02)00700-5 12633547 (Pubitemid 36286188)
141. J Wikstrand A Hjalmarson F Waagstein B Fagerberg S Goldstein J Kjekshus H Wedel 2002 Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF) J Am Coll Cardiol 40 491 498 10.1016/S0735-1097(02)01970-8 12142116 (Pubitemid 34833165)
142. T Rau R Heide K Bergmann H Wuttke U Werner N Feifel T Eschenhagen 2002 Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment Pharmacogenetics 12 465 472 10.1097/00008571-200208000-00007 12172215 (Pubitemid 34913529)
143. T Giessmann C Modess U Hecker M Zschiesche P Dazert C Kunert-Keil R Warzok G Engel W Weitschies I Cascorbi HK Kroemer W Siegmund 2004 CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects Clin Pharmacol Ther 75 213 222 10.1016/j.clpt.2003.10.004 15001973 (Pubitemid 38314871)
144. R Jahns V Boivin V Schwarzbach G Ertl MJ Lohse 2008 Pathological autoantibodies in cardiomyopathy Autoimmunity 41 454 461 10.1080/ 08916930802031603 18781471
145. K Fox I Ford PG Steg M Tendera R Ferrari 2008 Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial Lancet 372 807 816 10.1016/S0140-6736(08)61170-8 18757088
146. T Onda Y Hashimoto M Nagai H Kuramochi S Saito H Yamazaki Y Toya I Sakai CJ Homcy K Nishikawa Y Ishikawa 2001 Type-specific regulation of adenylyl cyclase. Selective pharmacological stimulation and inhibition of adenylyl cyclase isoforms J Biol Chem 276 47785 47793 11602596
147. NC Lai DM Roth MH Gao T Tang N Dalton YY Lai M Spellman P Clopton HK Hammond 2004 Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure Circulation 110 330 336 10.1161/01.CIR.0000136033.21777.4D 15249510 (Pubitemid 38955502)
148. AS Shah DC White S Emani AP Kypson RE Lilly K Wilson DD Glower RJ Lefkowitz WJ Koch 2001 In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction Circulation 103 1311 1316 10.1161/hc2501.092494 11238278
149. DM Bers 2006 Altered cardiac myocyte Ca regulation in heart failure Physiology (Bethesda) 21 380 387 10.1152/physiol.00019.2006 (Pubitemid 44879246)
150. Y Sato H Kiriazis A Yatani AG Schmidt H Hahn DG Ferguson H Sako S Mitarai R Honda L Mesnard-Rouiller KF Frank B Beyermann G Wu K Fujimori GW Dorn II EG Kranias 2001 Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation J Biol Chem 276 9392 9399 10.1074/jbc.M006889200 11115498
151. S Minamisawa M Hoshijima G Chu CA Ward K Frank Y Gu ME Martone Y Wang J Ross Jr EG Kranias WR Giles KR Chien 1999 Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy Cell 99 313 322 10.1016/S0092-8674(00)81662-1 10555147 (Pubitemid 29519910)
152. S Engelhardt L Hein V Dyachenkow EG Kranias G Isenberg MJ Lohse 2004 Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation Circulation 109 1154 1160 10.1161/01.CIR.0000117254.68497.39 14967726 (Pubitemid 38332620)
153. H Kiriazis Y Sato VJ Kadambi AG Schmidt MJ Gerst BD Hoit EG Kranias 2002 Hypertrophy and functional alterations in hyperdynamic phospholamban-knockout mouse hearts under chronic aortic stenosis Cardiovasc Res 53 372 381 10.1016/S0008-6363(01)00487-4 11827688 (Pubitemid 34117688)
154. Q Song AG Schmidt HS Hahn AN Carr B Frank L Pater M Gerst K Young BD Hoit BK McConnell K Haghighi CE Seidman JG Seidman GW Dorn II EG Kranias 2003 Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy J Clin Invest 111 859 867 12639992
155. U Delling MA Sussman JD Molkentin 2000 Re-evaluating sarcoplasmic reticulum function in heart failure Nat Med 6 942 943 10.1038/79592 10973288
156. M Hoshijima Y Ikeda Y Iwanaga S Minamisawa MO Date Y Gu M Iwatate M Li L Wang JM Wilson Y Wang J Ross Jr KR Chien 2002 Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery Nat Med 8 864 871 12134142
157. F del Monte SE Harding GW Dec JK Gwathmey RJ Hajjar 2002 Targeting phospholamban by gene transfer in human heart failure Circulation 105 904 907 10.1161/hc0802.105564 11864915 (Pubitemid 34184564)
158. Y Iwanaga M Hoshijima Y Gu M Iwatate T Dieterle Y Ikeda MO Date J Chrast M Matsuzaki KL Peterson KR Chien J Ross Jr 2004 Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats J Clin Invest 113 727 736 14991071
159. F del Monte E Williams D Lebeche U Schmidt A Rosenzweig JK Gwathmey ED Lewandowski RJ Hajjar 2001 Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure Circulation 104 1424 1429 10.1161/hc3601.095574 11560860
160. Y Kawase HQ Ly F Prunier D Lebeche Y Shi H Jin L Hadri R Yoneyama K Hoshino Y Takewa S Sakata R Peluso K Zsebo JK Gwathmey JC Tardif JF Tanguay RJ Hajjar 2008 Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure J Am Coll Cardiol 51 1112 1119 10.1016/j.jacc.2007.12.014 18342232
161. Y Chen B Escoubet F Prunier J Amour WS Simonides B Vivien C Lenoir M Heimburger C Choqueux B Gellen B Riou JB Michel WM Franz JJ Mercadier 2004 Constitutive cardiac overexpression of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias Circulation 109 1898 1903 10.1161/01.CIR.0000124230.60028.42 15037529 (Pubitemid 38509126)
162. K Haghighi F Kolokathis L Pater RA Lynch M Asahi AO Gramolini GC Fan D Tsiapras HS Hahn S Adamopoulos SB Liggett GW Dorn II DH MacLennan DT Kremastinos EG Kranias 2003 Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human J Clin Invest 111 869 876 12639993
163. RJ Hajjar K Zsebo L Deckelbaum C Thompson J Rudy A Yaroshinsky H Ly Y Kawase K Wagner K Borow B Jaski B London B Greenberg DF Pauly R Patten R Starling D Mancini M Jessup 2008 Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure J Card Fail 14 355 367 10.1016/j.cardfail.2008.02.005 18514926 (Pubitemid 351756538)
164. M Rocchetti A Besana G Mostacciuolo R Micheletti P Ferrari S Sarkozi C Szegedi I Jona A Zaza 2005 Modulation of sarcoplasmic reticulum function by Na+/K+pump inhibitors with different toxicity: digoxin and PST2744 [(E, Z)-3-((2-aminoethoxy)imino)androstane-6, 17-dione hydrochloride] J Pharmacol Exp Ther 313 207 215 10.1124/jpet.104.077933 15576469 (Pubitemid 40411344)
165. M Gheorghiade JE Blair GS Filippatos C Macarie W Ruzyllo J Korewicki SI Bubenek-Turconi M Ceracchi M Bianchetti P Carminati D Kremastinos G Valentini HN Sabbah 2008 Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure J Am Coll Cardiol 51 2276 2285 10.1016/j.jacc.2008.03.015 18534276
166. SG Priori C Napolitano N Tiso M Memmi G Vignati R Bloise V Sorrentino GA Danieli 2001 Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia Circulation 103 196 200 11208676 (Pubitemid 32095402)
167. SE Lehnart M Mongillo A Bellinger N Lindegger BX Chen W Hsueh S Reiken A Wronska LJ Drew CW Ward WJ Lederer RS Kass G Morley AR Marks 2008 Leaky Ca2+release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice J Clin Invest 118 2230 2245 18483626
168. SE Lehnart XH Wehrens PJ Laitinen SR Reiken SX Deng Z Cheng DW Landry K Kontula H Swan AR Marks 2004 Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak Circulation 109 3208 3214 10.1161/01.CIR.0000132472.98675.EC 15197150
169. PJ Laitinen KM Brown K Piippo H Swan JM Devaney B Brahmbhatt EA Donarum M Marino N Tiso M Viitasalo L Toivonen DA Stephan K Kontula 2001 Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia Circulation 103 485 490 11157710 (Pubitemid 32116230)
170. LA Venetucci AW Trafford SC O'Neill DA Eisner 2007 Na/Ca exchange: regulator of intracellular calcium and source of arrhythmias in the heart Ann N Y Acad Sci 1099 315 325 10.1196/annals.1387.033 17446473 (Pubitemid 47092597)
171. SE Lehnart C Terrenoire S Reiken XH Wehrens LS Song EJ Tillman S Mancarella J Coromilas WJ Lederer RS Kass AR Marks 2006 Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias Proc Natl Acad Sci USA 103 7906 7910 10.1073/pnas.0602133103 16672364 (Pubitemid 43752879)
172. AL Taylor S Ziesche C Yancy P Carson R D'Agostino Jr K Ferdinand M Taylor K Adams M Sabolinski M Worcel JN Cohn 2004 Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2049 2057 10.1056/NEJMoa042934 15533851 (Pubitemid 39482498)
173. CA Milano LF Allen HA Rockman PC Dolber TR McMinn KR Chien TD Johnson RA Bond RJ Lefkowitz 1994 Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor Science 264 582 586 10.1126/science.8160017 8160017
174. GW Dorn II NM Tepe JN Lorenz WJ Koch SB Liggett 1999 Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice Proc Natl Acad Sci USA 96 6400 6405 10.1073/pnas.96.11.6400 10339599 (Pubitemid 29256677)
175. XJ Du XM Gao GL Jennings AM Dart EA Woodcock 2000 Preserved ventricular contractility in infarcted mouse heart overexpressing beta(2)-adrenergic receptors Am J Physiol Heart Circ Physiol 279 H2456 H2463 11045983
176. TA Kohout H Takaoka PH McDonald SJ Perry L Mao RJ Lefkowitz HA Rockman 2001 Augmentation of cardiac contractility mediated by the human beta(3)-adrenergic receptor overexpressed in the hearts of transgenic mice Circulation 104 2485 2491 10.1161/hc4501.098933 11705829
177. WJ Koch HA Rockman P Samama RA Hamilton RA Bond CA Milano RJ Lefkowitz 1995 Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor Science 268 1350 1353 10.1126/science.7761854 7761854
178. HA Rockman KR Chien DJ Choi G Iaccarino JJ Hunter J Ross Jr RJ Lefkowitz WJ Koch 1998 Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice Proc Natl Acad Sci USA 95 7000 7005 10.1073/pnas.95.12.7000 9618528 (Pubitemid 28278096)
179. SJ Matkovich A Diwan JL Klanke DJ Hammer Y Marreez AM Odley EW Brunskill WJ Koch RJ Schwartz GW Dorn II 2006 Cardiac-specific ablation of G-protein receptor kinase 2 redefines its roles in heart development and beta-adrenergic signaling Circ Res 99 996 1003 10.1161/01.RES.0000247932.71270.2c 17008600 (Pubitemid 44657803)
180. MA Crackower GY Oudit I Kozieradzki R Sarao H Sun T Sasaki E Hirsch A Suzuki T Shioi J Irie-Sasaki R Sah HY Cheng VO Rybin G Lembo L Fratta AJ Oliveira-dos-Santos JL Benovic CR Kahn S Izumo SF Steinberg MP Wymann PH Backx JM Penninger 2002 Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways Cell 110 737 749 10.1016/S0092-8674(02) 00969-8 12297047 (Pubitemid 35283963)
181. E Patrucco A Notte L Barberis G Selvetella A Maffei M Brancaccio S Marengo G Russo O Azzolino SD Rybalkin L Silengo F Altruda R Wetzker MP Wymann G Lembo E Hirsch 2004 PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects Cell 118 375 387 10.1016/j.cell.2004.07.017 15294162 (Pubitemid 39061117)
182. R Gilsbach M Brede N Beetz E Moura V Muthig C Gerstner F Barreto S Neubauer MA Vieira-Coelho L Hein 2007 Heterozygous alpha 2C-adrenoceptor- deficient mice develop heart failure after transverse aortic constriction Cardiovasc Res 75 728 737 10.1016/j.cardiores.2007.05.017 17597596 (Pubitemid 47238738)